Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberta Hoi

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Ejhaem|November 10, 2025
Warm Autoimmune Haemolytic Anaemia Management in Asia-Pacific: A Delphi Panel Expert Consensus and Systematic Literature ReviewPhil Choi, Alberta Hoi, Rong Fu, et al.
Arthritis Research & Therapy|May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort studyRangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
Internal Medicine Journal|May 30, 2026
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman diseaseDipti Talaulikar, Jun Yen Ng, Adam Bryant, et al.
International Journal of Rheumatic Diseases|July 2, 2026
The Asia Pacific League of Associations for Rheumatology (APLAR) Consensus Statements for the Management of Reproductive Issues in Autoimmune Rheumatic DiseasesVinod Ravindran, Madhuri H Radhakrishna, Sunitha Kayidhi, et al.
The Lancet. Rheumatology|January 23, 2024
Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort studyDiane Apostolopoulos, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Seminars in Arthritis and Rheumatism|June 11, 2026
OMERACT- determining a core domain set for Sjögren's disease: International focus group seriesDana D DiRenzo, Lee Ang, Caroline O'Brien, et al.
Frontiers in Immunology|September 5, 2018
The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1Jessica C Anania, Halina M Trist, Catherine S Palmer, et al.
The Lancet. Rheumatology|January 17, 2024
Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort studyVera Golder, Rangi Kandane-Rathnayake, Molla Huq, et al.
The Lancet. Rheumatology|January 17, 2024
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation studyVera Golder, Rangi Kandane-Rathnayake, Molla Huq, et al.
Nature Communications|February 6, 2024
Smith-specific regulatory T cells halt the progression of lupus nephritisPeter J Eggenhuizen, Rachel M Y Cheong, Cecilia Lo, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Ejhaem|November 10, 2025
Warm Autoimmune Haemolytic Anaemia Management in Asia-Pacific: A Delphi Panel Expert Consensus and Systematic Literature ReviewPhil Choi, Alberta Hoi, Rong Fu, et al.
Arthritis Research & Therapy|May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort studyRangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
Internal Medicine Journal|May 30, 2026
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman diseaseDipti Talaulikar, Jun Yen Ng, Adam Bryant, et al.
International Journal of Rheumatic Diseases|July 2, 2026
The Asia Pacific League of Associations for Rheumatology (APLAR) Consensus Statements for the Management of Reproductive Issues in Autoimmune Rheumatic DiseasesVinod Ravindran, Madhuri H Radhakrishna, Sunitha Kayidhi, et al.
The Lancet. Rheumatology|January 23, 2024
Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort studyDiane Apostolopoulos, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Seminars in Arthritis and Rheumatism|June 11, 2026
OMERACT- determining a core domain set for Sjögren's disease: International focus group seriesDana D DiRenzo, Lee Ang, Caroline O'Brien, et al.
Frontiers in Immunology|September 5, 2018
The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1Jessica C Anania, Halina M Trist, Catherine S Palmer, et al.
The Lancet. Rheumatology|January 17, 2024
Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort studyVera Golder, Rangi Kandane-Rathnayake, Molla Huq, et al.
The Lancet. Rheumatology|January 17, 2024
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation studyVera Golder, Rangi Kandane-Rathnayake, Molla Huq, et al.
Nature Communications|February 6, 2024
Smith-specific regulatory T cells halt the progression of lupus nephritisPeter J Eggenhuizen, Rachel M Y Cheong, Cecilia Lo, et al.
Pageof 9